agilon health, inc. (NYSE: AGL) Stock Analysis & Fundamentals

AGLagilon health, inc.

NYSE · US · Healthcare · Medical Care Facilities · agilonhealth.com

93.97USD+1.34%Mkt Cap: 1.56B $P/E: —Today

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscr…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$28.53BUSDP/E 16.8

THC

Tenet Healthcare Corporation

$21.62BUSDP/E 10.4

FME

Fresenius Medical Care AG

$11.72BUSDP/E 12.1

EHC

Encompass Health Corporation

The Ensign Group, Inc.

$10.64BUSDP/E 28.6

UHS

Universal Health Services, Inc. Class B

LifeStance Health Group Inc. Common Stock

$4.90BUSDP/E 98.7

CON

Concentra Group Holdings Parent Inc. Common Stock

National HealthCare Corporation

$3.67BUSDP/E 26.3

OPCH

Option Care Health, Inc.

$3.50BUSDP/E 17.7

BKD

Brookdale Senior Living Inc.

$2.89BUSD

AVAH

Aveanna Healthcare Holdings Inc.

Acadia Healthcare Company, Inc.

$2.55BUSD

GRDN

Guardian Pharmacy Services Inc. Class A Common Stock

$2.41BUSDP/E 36.5

Key Statistics

Company

Market Cap1.56B $

Enterprise Value1.40B $

Revenue (TTM)5.92B $

Gross Profit-160.02M $

Net Income (TTM)-391.35M $

Revenue/Share356.25 USD

Last Price93.97 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees856

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISINAU000000AGL7

Valuation

P/E (Trailing)—

P/E (Forward)45.12

PEG—

EV/EBITDA-5.86

EV/Revenue0.24

P/S0.26

P/B6.84

EPS (TTM)-15.08

EPS (Forward)2.06

52W Range

7.48069% of range133.04

52W High133.04 USD

52W Low7.480 USD

Profitability

Gross Margin-2.70%

Oper. Margin1.30%

EBITDA Margin-4.05%

Profit Margin-6.60%

ROE-308.79%

ROA-30.78%

Growth

Revenue Growth7.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-105.76M $

CapEx (TTM)43.11M $

FCF Margin-2.46%

FCF Yield-9.36%

Net Debt-152.18M $

Net Debt/EBITDA0.63

Balance Sheet

Debt/Equity0.29

Current Ratio1.08

Quick Ratio0.98

Book Value/Sh13.55 USD

Cash/Share11.05 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:25

Split DateMar 31, 2026

Analyst Consensus

Rating2.6 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)110.92 USD

Upside (mean)+18.0%

Target Range31.00 USD – 146.00 USD

$31.00+18.0% to mean$146.00

# Analysts13

Ownership

Shares Out.16.79M

Float10.93M

Insiders3.14%

Institutions96.52%

Short Interest

Short Ratio2.8d

Short % Float8.29%

Short % Out.5.19%

Shares Short872.24K

Short (prev mo.)723.17K

Technical

SMA 50106.18 (-11.5%)

SMA 20047.40 (+98.2%)

Beta3.05

S&P 52W Chg18.16%

Avg Vol (30d)334.14K

Avg Vol (10d)311.90K

Technical Indicators

RSI (14)46.0

MACD-3.6001

MACD Signal-3.1027

MACD Hist.-0.4974

BB Upper124.02 USD

BB Middle99.07 USD

BB Lower74.12 USD

BB Width50.36%

ATR (14)10.14 USD

Vol Ratio (20d)0.49x